Zhou Wei, Liu Zhulong, Wang Nana, Chen Xue, Sun Xiaozheng, Cheng Yufeng
Department of Radiation Oncology, Cheeloo College of Medicine, Qilu Hospital, Shandong University, Jinan 250100, China.
ACS Omega. 2022 Mar 30;7(14):12021-12029. doi: 10.1021/acsomega.2c00223. eCollection 2022 Apr 12.
Radiotherapy is one of the most widely used clinical treatments for tumors, but it faces limitations, such as poor X-ray retention at the tumor site. The use of radiosensitizers containing high elements is an effective way to enhance X-ray absorption. Here, we demonstrate a simple one-step method for the synthesis of UiO-66-NH(Hf) metal-organic framework nanoparticles for use as radiosensitizers in radiotherapy. The UiO-66-NH(Hf) nanoparticles had a diameter of less than 100 nm and were stable in the physiological environment. UiO-66-NH(Hf) induced apoptosis by enhancing X-ray absorption, as confirmed by and experiments. These characteristics make UiO-66-NH(Hf) a promising radiosensitizer for esophageal cancer radiotherapy.
放射疗法是肿瘤临床治疗中应用最为广泛的方法之一,但它存在局限性,比如在肿瘤部位的X射线滞留效果不佳。使用含高原子序数元素的放射增敏剂是增强X射线吸收的有效途径。在此,我们展示了一种简单的一步法来合成UiO-66-NH(Hf)金属有机框架纳米粒子,用作放射疗法中的放射增敏剂。UiO-66-NH(Hf)纳米粒子直径小于100纳米,在生理环境中稳定。通过[具体实验1]和[具体实验2]实验证实,UiO-66-NH(Hf)通过增强X射线吸收诱导细胞凋亡。这些特性使UiO-66-NH(Hf)成为一种有前景的用于食管癌放射治疗的放射增敏剂。
ACS Appl Mater Interfaces. 2019-11-21
J Colloid Interface Sci. 2021-3-15
J Nanobiotechnology. 2025-8-21
Asian J Pharm Sci. 2024-4
Front Chem. 2023-11-24
Front Bioeng Biotechnol. 2023-11-3
Nat Rev Clin Oncol. 2022-2
J Intern Med. 2021-9
Chem Soc Rev. 2020-12-21
Chem Commun (Camb). 2020-9-15